Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Hydrolysis method of capsular polysaccharide of different serotypes of Streptococcus pneumoniae

A technology of Streptococcus pneumoniae and capsular polysaccharide, which is applied in the directions of antibacterial drugs, multivalent vaccines, bacterial antigen components, etc., can solve the difficult operation of the preparation and purification of polysaccharide activated conjugates, poor immune effect, and viscosity of polysaccharide solution. big problem

Active Publication Date: 2018-01-16
BEIJING MINHAI BIOTECH
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Due to the large molecular weight of the capsular polysaccharide of Streptococcus pneumoniae, the viscosity of the polysaccharide solution is also large, making the steps of polysaccharide activation, conjugate preparation and purification difficult to operate
The use of macromolecular polysaccharides as raw material polysaccharides will lead to excessive cross-linking of the conjugates and excessive molecular weight of the conjugates, which will pose risks to the quality of the product and may make the immune effect worse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Hydrolysis method of capsular polysaccharide of different serotypes of Streptococcus pneumoniae
  • Hydrolysis method of capsular polysaccharide of different serotypes of Streptococcus pneumoniae
  • Hydrolysis method of capsular polysaccharide of different serotypes of Streptococcus pneumoniae

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 11、2、3、4、18

[0021] Example 1 Hydrolysis of 1, 2, 3, 4, 18C, 23F pneumococcal capsular polysaccharide

[0022] Dissolve polysaccharide 1-5mg with water for injection, make it dissolve completely, add the hydrogen peroxide that final concentration is 3% and final concentration and be 1mM zinc sulfate solution (the mass ratio that is equivalent to capsular polysaccharide, hydrogen peroxide and zinc sulfate is 1 -5:9:0.16), the reaction temperature is 50°C-80°C, and the reaction is 3-5 hours. Use a 10kD ultrafiltration membrane to carry out ultrafiltration concentration, 0.85% sodium chloride solution ultrafiltration and change the liquid, change the liquid 5 times, each time 8 times of volume dilution. Concentrate to 5 times the volume of the reaction mixture, purify with a Sepharose 4FF gel chromatography column, collect the separated peaks with a kD value of 0.2-0.6, collect and concentrate by ultrafiltration to the original loading volume, and freeze-dry to recover the capsular polysaccha...

Embodiment 2

[0023] Example 2 Hydrolysis of 6A, 7F, 9N, 14, 19F pneumococcal capsular polysaccharide

[0024] Dissolve polysaccharide 1-5mg with water for injection, make it dissolve completely, add the hydrogen peroxide that final concentration is 2% and final concentration be 1mM zinc sulfate solution (the mass ratio that is equivalent to capsular polysaccharide, hydrogen peroxide and zinc sulfate is 1 -5:6:0.161), the reaction temperature is 50°C-80°C, and the reaction is 3-5 hours. Use a 10kD ultrafiltration membrane to carry out ultrafiltration concentration, 0.85% sodium chloride solution ultrafiltration and change the liquid, change the liquid 5 times, each time 8 times of volume dilution. Concentrate to 5 times the volume of the reaction mixture, purify with a Sepharose 4FF gel chromatography column, collect the separated peaks with a kD value of 0.3-0.6, collect and concentrate by ultrafiltration to the original loading volume, and freeze-dry to recover the capsular polysaccharide...

Embodiment 3

[0025] Example 3 Hydrolysis of 5, 6B, 9V, 19A, 22F, 33F type pneumococcal capsular polysaccharide

[0026] Dissolve polysaccharide 1-5mg with water for injection, make it dissolve completely, add the hydrogen peroxide that final concentration is 1.5% and final concentration be 1mM zinc sulfate solution (the mass ratio that is equivalent to capsular polysaccharide, hydrogen peroxide and zinc sulfate is 1 -5:4.5:0.161), the reaction temperature is 50°C-80°C, and the reaction is 3-5 hours. Use a 10kD ultrafiltration membrane to carry out ultrafiltration and concentrate 0.85% sodium chloride solution and change the liquid by ultrafiltration, and change the liquid 5 times, each time 8 times of volume dilution. Concentrate to 5 times the volume of the reaction mixture, purify with Sepharose4FF gel chromatography, collect the separated peaks with a kD value of 0.35-0.65, collect and concentrate by ultrafiltration to the original loading volume, and freeze-dry to recover the hydrolysi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a hydrolysis method of different serotypes of streptococcus pneumoniae capsular polysaccharides. The hydrolysis method comprises steps as follows: a hydrogen dioxide solution and an inorganic salt solution are added to an aqueous solution of different serotypes of streptococcus pneumoniae capsular polysaccharides to hydrolyze polysaccharides, the reaction is performed for 3-5 h at the temperature of 50-80 DEG C, after the reaction is finished, a reaction mixture containing polysaccharide hydrolysis fragments with different sizes is subjected to ultrafiltration and concentration, an obtained product is purified through a Sepharose 4FF gel chromatography column, separation peaks with a kD value in a range from 0.2 to 0.65 are collected, and hydrolysis products of the different serotypes of streptococcus pneumoniae capsular polysaccharides are obtained after ultrafiltration and concentration as well as freeze-drying. With the adoption of the method, hydrolysis of the different serotypes of streptococcus pneumoniae capsular polysaccharides can be realized, the capsular polysaccharides are hydrolyzed into the fragments with different sizes, antigenicity of the hydrolysis fragments is reserved, the requirement of a preparation technology of a polyvalent pneumococcal conjugate vaccine is met, and the method can be used for preparation of the polyvalent pneumococcal conjugate vaccine applicable to infants at the age of 2 or younger.

Description

technical field [0001] The invention relates to the field of vaccine preparation, in particular to a method for hydrolyzing capsular polysaccharides of Streptococcus pneumoniae of different serotypes. Background technique [0002] Streptococcus pneumoniae or pneumococcal pneumonia is pneumonia caused by Streptococcus pneumoniae or Streptococcus pneumoniae. It usually has a sudden onset and is characterized by high fever, chills, cough, bloody sputum, and chest pain. Over the past two centuries, no infectious agent has matched the global morbidity and mortality of Streptococcus pneumoniae, responsible for the annual death of one million children under the age of 5 worldwide. Streptococcus pneumoniae remains the leading cause of community-acquired pneumonia, mainly causing lobar pneumonia in adults and bacterial pneumonia, meningitis, otitis media, and pleurisy in children. Before antibiotics, more than 70% of patients hospitalized for pneumonia bacteremia died. 20-48% of ac...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C08B37/00A61K39/116A61K39/09A61P31/04
CPCA61K39/09A61K2039/70C08B37/00
Inventor 任涛杨朝晖庞强安建峰缪凯陈旭刘建凯
Owner BEIJING MINHAI BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products